Topics:

Sentinel Lymph Node Mapping Studied in Lung Cancer

Sentinel Lymph Node Mapping Studied in Lung Cancer

CHICAGO—Intraoperative sentinel lymph node mapping using
technetium-99 sulfur colloid is a safe and feasible way of identifying sites of
lymph node metastasis in patients with non-small-cell lung cancer (NSCLC). The
procedure does not prolong surgical resection, and it is relatively accurate,
with an 89% success rate, Michael Liptay, MD, reported at the Second
International Chicago Symposium on Malignancies of the Chest and Head &
Neck.

"Sentinel lymph node mapping in lung cancer may allow pathologists to
provide more precise nodal staging information on the presence of
micrometastatic disease," said Dr. Liptay, assistant professor of thoracic
surgery, Northwestern University School of Medicine, Evanston, Illinois.

Dr. Liptay and his colleagues at Northwestern have been assessing sentinel
lymph node mapping in lung cancer patients for the last 2 years to determine if
it would improve staging.

Sentinel lymph node mapping is used in patients with breast cancer or
melanoma to limit potentially morbid and nontherapeutic nodal dissection. In
the lung, it may prove to be a sensitive pathologic technique for assessing
selected lymph nodes rather than the entire surgical specimen, he said.

Although lymph node involvement is the strongest predictor of survival for
patients with localized lung malignancies, nearly 40% of patients who appear to
have node-negative disease at pathologic analysis relapse within 2 years of
resection, Dr. Liptay noted. "It is our hypothesis that undetected and
occult metastases in the lymph nodes may explain some of these early
relapses," he said.

In Dr. Liptay’s study of 91 patients, 0.5 to 2.0 mCi of radioactive
technetium 99 sulfur colloid was injected directly into the tumor in a
four-quadrant pattern immediately following thoracotomy.

After 10 minutes of surgical dissection of lung tissue away from the
lymphatics in the peribronchial area, a hand-held gamma camera was used to
obtain readings of the primary tumor and lymph nodes. Lymph nodes identified as
the first nodal draining sites of solid lung tumors were examined in ten 20-µm
serial sections, and all dissected lymph nodes underwent antibody staining.

Pages

 
Loading comments...
Please Wait 20 seconds or click here to close